Concentric Capital Strategies’s Merck MRK Stock Holding History

Concentric Capital Strategies’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$420K	Buy	3,492 +1,059	+44%	+$122K	0.04%	233
2025 Q4	$256K	Sell	2,433 -114,797	-98%	-$10.8M	0.01%	245
2025 Q3	$9.84M	Buy	117,230 +114,556	+4,284%	+$9.44M	0.44%	65
2025 Q2	$212K	Buy	+2,674	New	+$213K	0.01%	263
2025 Q1	–	Sell	-2,596	Closed	-$258K	–	253
2024 Q4	$258K	Sell	2,596 -10,527	-80%	-$1.09M	0.01%	242
2024 Q3	$1.49M	Buy	13,123 +5,439	+71%	+$646K	0.06%	223
2024 Q2	$951K	Sell	7,684 -58,954	-88%	-$7.59M	0.05%	251
2024 Q1	$8.79M	Buy	+66,638	New	+$8.21M	0.49%	56
2023 Q4	–	Sell	-4,072	Closed	-$419K	–	291
2023 Q3	$419K	Buy	+4,072	New	+$439K	0.04%	180

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Concentric Capital Strategies's MRK Position: Q1 2026 in Review

Concentric Capital Strategies increased its Merck (MRK) stake by 44% in Q1 2026, buying an estimated $122K and bringing the position to 3,492 shares worth $420K. The position accounts for 0.04% of the portfolio, ranked #233.

Concentric Capital Strategies first reported a position in MRK in Q3 2023 and has held it in 9 quarters since. The position peaked at $9.84M in Q3 2025. 3,781 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Concentric Capital Strategies held 3,492 shares of Merck worth $420K as of Q1 2026.
Concentric Capital Strategies bought 1,059 Merck shares in Q1 2026, an estimated $122K.
Merck made up 0.04% of Concentric Capital Strategies's portfolio in Q1 2026, its #233 holding.
Concentric Capital Strategies first reported a position in Merck in Q3 2023 and has held it in 9 quarters since.
Concentric Capital Strategies's Merck position peaked at $9.84M in Q3 2025.
3,781 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Concentric Capital Strategies's 13F filing for Q1 2026, filed 15 May 2026.